Intrinsic Value of S&P & Nasdaq Contact Us

Forte Biosciences, Inc. FBRX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$65.00
+100.5%

Stock Statistics — FBRX

Forte Biosciences, Inc. (FBRX) has a market capitalization of $450.17M and trades at $32.42. The 52-week range is 4.9-35.62.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.9, Earnings Per Share (EPS) of $-4.71.

The stock has a beta of 3.23, operates in the Healthcare sector.

Trading Data
Current Price$32.42
52-Week Range4.9-35.62
Volume290.29K
Avg Volume (30D)283.43K
Market Cap$450.17M
Beta (1Y)3.23
Company
IPO Date2017-04-13
Employees14
CEOPaul A. Wagner
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS34962G2084
CUSIP34962G109
Income (Latest Year)
EBITDA$-70.66M
Operating Income$-70.66M
Net Income$-69.38M
EPS$-4.71
EPS Diluted$-4.71
Shares Outstanding$147.18M
Balance Sheet (Latest Year)
Total Assets$82.78M
Current Assets$80.59M
Cash & ST Investments$76.96M
Total Liabilities$21.79M
Net Debt$-76.96M
Total Equity$60.99M
Valuation Ratios
P/E Ratio-6.9
P/B Ratio7.38
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message